JAN 24, 2019 11:46 PM PST

Why Do Promising Cancer Drugs Fail?

WRITTEN BY: Nouran Amin

After almost 20 years of a once-promising cancer drugs known as MMP inhibitors suddenly failed in clinical trials, scientists are now eager to provide an explanation.

MMP inhibitors, known as matrix metalloproteinases, originally work by targeting enzymes thought to be responsible for the spread of cancer. The results in the model C. elegans worms can lead to more effective ways to prevent the initial steps of metastasis, in what results in about 90 percent of all tumor-related deaths.

Learn more about MMPs in cancer metastasis:

Despite the promising results of MMP inhibitors in mice, they were not successful in people with some patients developing serious side effects. New findings suggest that maybe cancerous cells will convert themselves to a brute force when no dissolving enzymes are available. Findings were published in Developmental Cell.

Caption: This image shows the uncontrolled growth of cells in squamous cell carcinoma.

Credit: Markus Schober and Elaine Fuchs, The Rockefeller University, New York via NIH

The study suggested that the reason why MMPs did not work on human tumors is because--“Normal worm cells use their MMP enzymes to help cut through the matrix of proteins in the basement membrane like molecular scissors, the researchers say. But cells in "knockout" worms lacking the MMP enzymes instead build a large protrusion that pummels and smashes its way through with brute force,” said experimental leader and research scientist,” Laura Kelley.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 29, 2018
Cannabis Sciences
NOV 29, 2018
Want to Smoke Weed? For Science?
Clinical trials are a necessary part of the drug approval process. All drugs on the market, even the over-the-counter drugs, have gone through clinical tri...
DEC 06, 2018
Drug Discovery
DEC 06, 2018
Repurposing Cancer Drugs For HPV Treatment
Drug repurposing is transforming the health care world. The idea that old, previously-- FDA approved drugs could be altered and to be used again for the tr...
DEC 23, 2018
Drug Discovery
DEC 23, 2018
Preventive Drug Decreases Cases of Leprosy in Morocco
Leprosy, also known as Hansen disease, is a disabling chronic and infectious disease that affects the skin and the peripheral nerves. It has a huge effect ...
DEC 23, 2018
Drug Discovery
DEC 23, 2018
Buruli ulcer: promising drug for a forgotten disease
One of the most forgotten and neglected diseases is Buruli ulcer, a debilitating and stigmatized condition affecting primarily children in West and Central...
DEC 26, 2018
Drug Discovery
DEC 26, 2018
Novel Water Approach May Improve Drug Design
An understanding of the basic molecular properties of water greatly influences drug design. But, a significant comprehension of water interactions and its ...
JAN 01, 2019
Drug Discovery
JAN 01, 2019
Restoring The Fountain of Youth
According to a study published in Nature Communications, a drug treatment that aided the immune system in eradicating old cells in aging mice assisted in t...
Loading Comments...